- Funding & Notices
- News & Media
- About Translation
- About NCATS
NCATS-supported researchers sent miniaturized tissue chip systems to the International Space Station on May 4. Four projects using the systems will support the study of aging-related conditions and potential treatments for them.May E-Newsletter Now Available
Scientists in NCATS’ Assay Development and Screening Technology program are developing new methods for screening small molecules that could help researchers test possible drugs and develop new treatments for many diseases.
Staff who work on clinical studies can improve their skills with high-quality training materials on the DIAMOND portal. The goal of the CTSA Program-supported DIAMOND project is to create well-run clinical trials through well-trained staff.
Rare Disease Day at NIH, held this year on Feb. 28, exemplifies NCATS’ approach to rare diseases research: involving patients as partners throughout the translational research process to ensure that research and interventions address patients’ needs.
Scientists at Brigham and Women’s Hospital collaborated with NCATS high-throughput screening experts to develop a different approach against inflammation, identifying four compounds that can potentially turn on anti-inflammatory activity.
Clinical and Translational Science Awards Program
Apply Now for the ASPIRE Design Challenges
The NCATS ASPIRE Design Challenges are designed to advance innovative and catalytic approaches towards solving the opioid crisis by developing “A Specialized Platform for Innovative Research Exploration” (ASPIRE) to aid in the discovery and development of novel and effective treatments, while at the same time making the process faster and more cost-effective. The NCATS ASPIRE Design Challenges are part of the of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to the national opioid public health crisis. Learn more about the ASPIRE Design Challenges.